387 related articles for article (PubMed ID: 24491019)
1. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X
Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan.
Fu Y; Zhao J; Atagi Y; Nielsen HM; Liu CC; Zheng H; Shinohara M; Kanekiyo T; Bu G
Mol Neurodegener; 2016 May; 11(1):37. PubMed ID: 27151330
[TBL] [Abstract][Full Text] [Related]
4. Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease.
Martiskainen H; Haapasalo A; Kurkinen KM; Pihlajamäki J; Soininen H; Hiltunen M
Expert Opin Ther Targets; 2013 Jul; 17(7):781-94. PubMed ID: 23573918
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.
Bilousova T; Melnik M; Miyoshi E; Gonzalez BL; Poon WW; Vinters HV; Miller CA; Corrada MM; Kawas C; Hatami A; Albay R; Glabe C; Gylys KH
Am J Pathol; 2019 Aug; 189(8):1621-1636. PubMed ID: 31108099
[TBL] [Abstract][Full Text] [Related]
6. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
[TBL] [Abstract][Full Text] [Related]
7. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA.
Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T
Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438
[TBL] [Abstract][Full Text] [Related]
8. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.
Bachmeier C; Shackleton B; Ojo J; Paris D; Mullan M; Crawford F
Neuromolecular Med; 2014 Dec; 16(4):686-96. PubMed ID: 25015123
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.
Kanekiyo T; Zhang J; Liu Q; Liu CC; Zhang L; Bu G
J Neurosci; 2011 Feb; 31(5):1644-51. PubMed ID: 21289173
[TBL] [Abstract][Full Text] [Related]
12. Functional role of lipoprotein receptors in Alzheimer's disease.
Jaeger S; Pietrzik CU
Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E receptor pathways in Alzheimer disease.
Schmidt V; Carlo AS; Willnow TE
Wiley Interdiscip Rev Syst Biol Med; 2014; 6(3):255-70. PubMed ID: 24604742
[TBL] [Abstract][Full Text] [Related]
15. LRP1 expression in cerebral cortex, choroid plexus and meningeal blood vessels: relationship to cerebral amyloid angiopathy and APOE status.
Ruzali WA; Kehoe PG; Love S
Neurosci Lett; 2012 Sep; 525(2):123-8. PubMed ID: 22967844
[TBL] [Abstract][Full Text] [Related]
16. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
17. Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease.
Watanabe N; Araki W; Chui DH; Makifuchi T; Ihara Y; Tabira T
FASEB J; 2004 Jun; 18(9):1013-5. PubMed ID: 15084524
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
Donahue JE; Johanson CE
J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
[TBL] [Abstract][Full Text] [Related]
19. LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer's Disease.
Van Gool B; Storck SE; Reekmans SM; Lechat B; Gordts PLSM; Pradier L; Pietrzik CU; Roebroek AJM
Mol Neurobiol; 2019 Oct; 56(10):7234-7245. PubMed ID: 31004319
[TBL] [Abstract][Full Text] [Related]
20. Possible link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's disease: A role for high-density lipoproteins?
Mulder M; Terwel D
Haemostasis; 1998; 28(3-4):174-94. PubMed ID: 10420065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
